These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 9464540

  • 21. G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation.
    Juan G, Ardelt B, Li X, Mikulski SM, Shogen K, Ardelt W, Mittelman A, Darzynkiewicz Z.
    Leukemia; 1998 Aug; 12(8):1241-8. PubMed ID: 9697879
    [Abstract] [Full Text] [Related]

  • 22. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4.
    Blain SW, Montalvo E, Massagué J.
    J Biol Chem; 1997 Oct 10; 272(41):25863-72. PubMed ID: 9325318
    [Abstract] [Full Text] [Related]

  • 23. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells.
    Teixeira C, Pratt MA.
    Mol Endocrinol; 1997 Aug 10; 11(9):1191-202. PubMed ID: 9259311
    [Abstract] [Full Text] [Related]

  • 24. The N-terminal domains of cyclin-dependent kinase inhibitory proteins block the phosphorylation of cdk2/Cyclin E by the CDK-activating kinase.
    Rank KB, Evans DB, Sharma SK.
    Biochem Biophys Res Commun; 2000 May 10; 271(2):469-73. PubMed ID: 10799321
    [Abstract] [Full Text] [Related]

  • 25. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes.
    Cheney IW, Neuteboom ST, Vaillancourt MT, Ramachandra M, Bookstein R.
    Cancer Res; 1999 May 15; 59(10):2318-23. PubMed ID: 10344736
    [Abstract] [Full Text] [Related]

  • 26. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM, Hay N, Liao S.
    Mol Endocrinol; 1998 Jul 15; 12(7):941-53. PubMed ID: 9658399
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J.
    Cancer Radiother; 2001 Apr 15; 5(2):109-29. PubMed ID: 11355576
    [Abstract] [Full Text] [Related]

  • 29. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
    Schrantz N, Beney GE, Auffredou MT, Bourgeade MF, Leca G, Vazquez A.
    J Immunol; 2000 Oct 15; 165(8):4346-52. PubMed ID: 11035070
    [Abstract] [Full Text] [Related]

  • 30. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G, Hunter T, Ruoslahti E.
    Oncogene; 1998 May 15; 16(20):2575-83. PubMed ID: 9632134
    [Abstract] [Full Text] [Related]

  • 31. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
    Chen WJ, Chang CY, Lin JK.
    Biochem Pharmacol; 2003 Jun 01; 65(11):1777-85. PubMed ID: 12781329
    [Abstract] [Full Text] [Related]

  • 32. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
    Watts CK, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL.
    Mol Endocrinol; 1995 Dec 01; 9(12):1804-13. PubMed ID: 8614416
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cell cycle-mediated regulation of hepatic regeneration.
    Ehrenfried JA, Ko TC, Thompson EA, Evers BM.
    Surgery; 1997 Nov 01; 122(5):927-35. PubMed ID: 9369893
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
    Ravanko K, Järvinen K, Paasinen-Sohns A, Hölttä E.
    Cancer Res; 2000 Sep 15; 60(18):5244-53. PubMed ID: 11016654
    [Abstract] [Full Text] [Related]

  • 37. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.
    Baldassarre G, Barone MV, Belletti B, Sandomenico C, Bruni P, Spiezia S, Boccia A, Vento MT, Romano A, Pepe S, Fusco A, Viglietto G.
    Oncogene; 1999 Nov 04; 18(46):6241-51. PubMed ID: 10597222
    [Abstract] [Full Text] [Related]

  • 38. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.
    Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM.
    Proc Natl Acad Sci U S A; 2000 Aug 01; 97(16):9042-6. PubMed ID: 10908655
    [Abstract] [Full Text] [Related]

  • 39. Cyclin E-CDK2 is a regulator of p27Kip1.
    Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE.
    Genes Dev; 1997 Jun 01; 11(11):1464-78. PubMed ID: 9192873
    [Abstract] [Full Text] [Related]

  • 40. Alterations in cyclin-dependent kinase 2 function during differentiation of primary human keratinocytes.
    Alani RM, Hasskarl J, Münger K.
    Mol Carcinog; 1998 Dec 01; 23(4):226-33. PubMed ID: 9869451
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.